Table 2.
Clinical outcomes of the study.
| Variable | N (%) | COVID-19, n(%) |
P-value | ||
|---|---|---|---|---|---|
| Negative | Positive | ||||
| Admission to ICU | Yes | 17 (11.3) | 0 (0.0) | 17 (100.0) | <0.001 |
| No | 134 (88.7) | 109 (81.3) | 25 (18.7) | ||
| Death | Yes | 32 (21.2) | 13 (40.6) | 19 (59.4) | <0.001 |
| No | 119 (78.8) | 96 (80.7) | 23 (19.3) | ||
| Duration of hospitalization*, (days) | 7.78±10.42 | 7.52±11.20 | 8.50±7.86 | 0.021 | |
| Baseline MRS* | 4.55±0.67 | 4.46±0.67 | 4.79±0.61 | 0.001 | |
| Final MRS* | 4.13±1.30 | 3.83±1.22 | 4.93±1.18 | <0.001 | |
⁎
Values shown by mean ± SD, ICU: intensive care unit, MRS: modified Rankin Scale, COVID-19: Coronavirus disease 2019, SD: Standard deviation.